Associate Professor and Chief, Colorectal Surgery, UCLA Medical Center

Colon & Rectal Surgery

Dr. Kevork Kazanjian practices Colon & Rectal Surgery. He attended David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA has a rank of 13 in research and a 7 in primary care He received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FASCRS)" and "Fellow (FACS)". Kevork Kazanjian has written publications. He has 23 publications published with PubMed. The lastest paper is: 'Alcohol fat clearing increases lymph node yield after surgery for colorectal cancer.' He accepts Medicare.

Publications

---

• Alcohol fat clearing increases lymph node yield after surgery for colorectal Cancer.
• Surgical and radiation therapy management of recurrent Anal melanoma.
• Down-regulation of LXR/RXR activation and negative acute phase response pathways in colon adenocarcinoma revealed by proteomics and bioinformatics Analysis.
• Outcomes of Multimodality Therapies for Patients With Stage II or III Rectal Cancer in California, 1994-2009.
• When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections.
• Predictors of delayed-stage colorectal Cancer: are we neglecting critical demographic information?
• Accuracy and upgrade rates of percutaneous breast biopsy: the surgeon's role.
• The use of pelvic radiation in stage II rectal cancer: a population-based Analysis.
• Time from diagnosis to surgical treatment of breast Cancer: factors influencing delays in initiating treatment.
• Are percutaneous biopsy rates a reasonable quality measure in breast Cancer management?
• Factors associated with variance in compliance with a sentinel lymph node dissection quality measure in early-stage breast Cancer.
• Impact of splenectomy on thrombocytopenia, chemotherapy, and survival in patients with unresectable pancreatic Cancer.
• Improved survival following pancreaticoduodenectomy to treat adenoCarcinoma of the pancreas: the influence of operative blood loss.
• Distal pancreatectomy: incidence of postoperative diabetes.
• Unfavourable prognosis associated with K-ras gene mutation in pancreatic Cancer surgical margins.
• Resection of pancreatic Neuroendocrine tumors: results of 70 cases.
• The clinical significance of MAGEA3 expression in pancreatic Cancer.
• The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic Cancer cell invasion by amplifying mitogen-activated protein kinase...
• Management of pancreatic Fistulas after pancreaticoduodenectomy: results in 437 consecutive patients.
• Laparoscopic gastrojejunostomy for gastric outlet obstruction in pancreatic Cancer.
• Peptide YY exhibits a mitogenic effect on pancreatic cells while improving acute pancreatitis in vitro.
• Hypophosphorylated retinoblastoma protein is associated with G2 arrest in esophageal squamous cell Carcinoma.

Schools

---

• University Of California Los Angeles School Of Medicine

• UCLA Medical Center

• University Of Minnesota Hosp amp Clinic

• University Of California Los Angeles UCLA

• UCLA Surgical Oncology Research Fellowship

Procedures Preformed

---

• Advanced Laparoscopic Surgery
• Anal Repair
• Anoscopy With Removal of Anal Tumor
• Appendectomy, Open
• View All

Conditions Treated

---

• Anal Cancer
• Anal Fissure
• Anal Fistula
• Anemia
• View All

Doctors Specialties

---

• General Surgery
• Surgical Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Fellow (FASCRS)
• Fellow (FACS)

Education

---

• University of Minnesota
• UCLA Medical Center
• David Geffen School of Medicine at UCLA

Hospital

---

• Santa Monica-UCLA Medical Center and Orthopaedic Hospital
• Ronald Reagan UCLA Medical Center

Drug Facts

---

NPI NUMBER		1053591941
NPPES Provider LastName		KAZANJIAN
NPPES Provider FirstName		KEVORK
NPPES Provider ZIPCode		90095
NPPES Provider State		CA
Specialty Description		Colorectal Surgery (formerly proctology)
Total Claim Count		93.0
Distinct Opioid Count		1.0
Opioid Claim Count		22.0
Percent Opioid Claims		23.66

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1053591941
Last Name Of The Provider	KAZANJIAN
First Name Of The Provider	KEVORK
View All

Similar Doctors

---

	Dr. Kyle G. Cologne, MD This Doctor is OpenDoctor Recommended.
	Dr. Adil Farooqui, MD This Doctor is OpenDoctor Recommended.
	Dr. Yosef Y. Nasseri, MD This Doctor is OpenDoctor Recommended.
	Dr. Elisabeth C. McLemore, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Hamed Kargozaran, MD
	Dr. Douglas G. Farmer, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Clifford Y. Ko, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Bobby J. Harris, MD This Doctor is OpenDoctor Recommended.
	Dr. Philip I. Haigh, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Edgardo M. Capitulo, MD This Doctor is OpenDoctor Recommended.
	Dr. Keri E. Lunsford, MD This Doctor is OpenDoctor Recommended.
	Dr. Clarence W. Cole, MD This Doctor is OpenDoctor Recommended.
	Dr. Eric Culbertson, MD This Doctor is OpenDoctor Recommended.
	Dr. Christina L. Greene, MD This Doctor is OpenDoctor Recommended.
	Dr. Adrian E. Ortega, MD This Doctor is OpenDoctor Recommended.
	Dr. Victoria Stager, MD This Doctor is OpenDoctor Recommended.
	Dr. Nir Wasserberg, MD This Doctor is OpenDoctor Recommended.
	Dr. Mu Xu, MD
	Dr. Maher A. Abbas, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog